Join the Conversation at RESI

8 Sep

By Caitlin Dolegowski, Marketing Specialist, LSN

The Redefining Early Stage Investments (RESI) conference series is returning to Boston in T-minus two weeks! This conference will be a hybrid event taking place onsite September 21-22, with an additional day of virtual partnering Friday, September 23. The excitement of our first in-person event in over two years is compounded by the list of panelists featured at RESI Boston. Panels are crafted with the early-stage, life science entrepreneur at the forefront and the line-up at RESI Boston will be teeming with valuable content, insights, and takeaways for our attendees. Panelists will consist of investors, industry experts, and seasoned entrepreneurs covering trending topics that provide insight to fundraising startups across the silos of drugs, devices, diagnostics, and digital health (4Ds). Our panels will be live and in-person at RESI Boston with recordings available to our virtual attendees via the live agenda.

There is still time to sign up for RESI Boston! Register today to begin partnering with these innovators and more!

September 21 – 9 AM
Angels Panel

Explaining the Process of Engagement

Charles Cameron
Founder & Managing Director
Hub Angels Investment Group

Elizabeth Cho-Fertikh
Co-Founder & Managing Director
Meda Angels

Dave Fogel
Member of Screening & Due Diligence Committees
Mass Medical Angels

Wei Tao
Board Director & Chair, Bio/Genomics
Life Science Angels

September 21 – 10 AM
Medical Devices Panel

Investing in Novel Engineering

Sam Goldberger
Co-Founder & Managing Partner
Ambit Health Ventures

Z Haroon
Chairman & General Partner
Julz Co.

Kristin King
Boston Harbor Angels

Brock Reeve
Co-Founder & CEO
Eos BioInnovation

Maria Shepherd
Founder & CEO

September 21 – 11 AM
Tales from the Road Panel

The Fundraising Biotech Founder

Auriane Gamelin, MBA
Co-Founder & COO

Collin Horner
Co-Founder & CBO
Cura Therapeutics

Stanley Kim
Co-Founder & CEO
WinSanTor Bio

John Ramunas, PhD
Co-Founder & CEO
Rejuvenation Technologies

Courtney Young
Co-Founder & CEO
MyoGene Bio

September 21 – 1 PM
Diagnostics Panel

Next-Gen Tech Changing Treatment Paradigms

Tom Miller 
Managing Partner
GreyBird Ventures

Bruce Cohen
Xeraya Capital

Alex de Winter
Vice President, New Ventures
Danaher Corporation

Josh Phillips
Founder & Managing Partner
Catalyst Health Ventures 

Shuo Huang
Senior Investment Manager
Baidu Ventures

September 21 – 2 PM
Tales from the Road Panel

AI at the Intersection of Health & Tech

Robert Quinn
Co-Founder & CEO
Patchd Medical

Alicia Chong Rodriguez
Founder & CEO
Bloomer Tech 

Jessica Gibson
President & CEO
Ariel Precision Medicine

Nan-Wei Gong, PhD

Jinwoo Kim, PhD
Founder & CEO
HAII Therapeutics 

September 21 – 3 PM
New, Now, and Next in Longevity Investment Panel

Opportunities & Priorities in Age-Tech

Joshua Barney, JD 
Barrington Angels

Moshe Bellows, JD
General Partner
Maccabee Ventures

Lisa Fabiny-Kiser, MBA
SENS Research Foundation

Ray Jang, MBA
Senior Associate
Primetime Partners

Jenny Poth
Vice President, Proprietary Investments
Ziegler LinkAge

September 21 – 4 PM
Family Offices Panel

Perspectives on Seed & Series A Rounds

Catherine Zhang 
Partner & Management Committee
Kajko, Weisman & Colasanti, LLP

Sherry Grisewood
Senior Investment Officer
FoxHill Asset Management

Ron Paliwoda
Founder & President
Paliwoda Group

September 22 – 9 AM
Digital Health Panel

Leveraging Software, Lowering Costs & Improving Care

Arianne Kidder
Seae Ventures

Tomoko Ishikura
Kicker Ventures

Vic Lanio
Flare Capital Partners

Cyril Philip
Vice President, Digital Ventures
Bon Secours Mercy Health

Matt Weinberg
Max Ventures

September 22 – 10 AM
Big Pharma Panel

Strategies for Preclinical & Early Clinical Assets

Steve Cohen
Executive Director, Translational Medicine-Oncology & Internal Medicine, & Search & Evaluation
Daiichi Sankyo

Jennifer Ma
Executive Director, Business Development & Licensing

Jim MacKrell
Associate Vice President & Head, Boston Venture Science Team
Eli Lilly

Imran Nasrullah
Vice President & Head, Collaborate2Cure Hub US, Business Development & Licensing

September 22 – 11 AM
Tales from the Road Panel

Medtech Startups Redefining Possibility

Maria Shepherd
President & CEO

Angie Conley

Michael Finkelstein
Vice President, Research & Strategy
Neuro20 Technologies

Brian Hess

David Robertson
Asyst Medical

September 22 – 1 PM
Corporate VC Panel

The Changing Landscape & New Opportunities

Andy Merken
Partner, Corporate & Securities Co-Chair, Life Sciences
Burns & Levinson

Rowan Cade
Program Manager
BARDA Ventures (Division of Research Innovation and Ventures (DRIVe))

Adam Kundzewicz
Executive Director
Boehringer Ingelheim Venture Fund

Jasmina Marjanovic
AbbVie Ventures

Ronak Salva
Director, Strategic Ventures
Catalent Strategic Ventures

September 22 – 2 PM
AI Healthcare Investments Panel

Defining Tech and Discovering Potential

Wasim Q. Malik, PhD
Managing Partner
Iaso Ventures

Lana Caron, MBA
Managing Partner & Innovation Lead
Philips Ventures 

Poorya Hosseini, PhD
Camford Capital 

Lu Zhang
Managing Partner
Fusion Fund 

September 22 – 3 PM
Tales from the Road Panel

Age-Tech Innovators on Their Fundraising Journey

Steve Weissblum, MBA
Mentor-in-Residence, Techstars Future of Longevity Accelerator

Wendy Bronfin

Anthony DePasqua, MBA
EnClear Therapies

Chekesha Kidd, MBA, MHSA
Senior Health & Wellness Executive

Sam Yang
Managing Director & Co-Founder
Xandar Kardian

September 22 – 4 PM
Oncology Innovation Panel

The Search for New Approaches to Diagnosing & Treating Cancer

Kalyan Chakravarthy
Senior Manager, External Innovation

Miles Gerson
Senior Investment Director & Partner
Takeda Ventures

Andrew Meadow
General Partner
Health Innovation Capital

Atul Varadhachary
Managing Partner
Fannin Innovation Studio


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: